Felix Olale, MD, PhD, is a partner in LeapFrog Investments. An entrepreneur, innovator, physician-scientist, and advisor, Dr. Olale is known for his work building businesses and investing in health care in emerging markets. He has led and advised on transactions of more than US$100 million in financing across Africa and holds a number of board appointments, including chairing PATH’s governance committee and the advisory board of the Institute for Healthcare Management at Strathmore Business School in Nairobi.
Prior to LeapFrog, Dr. Olale was executive chairman of the Excelsior Group, a US- and Kenya-based advisor in emerging markets. While at Excelsior, he cofounded Wellness Group, an East African specialty consultation and medical diagnostics company. Dr. Olale is also a founding member of the Healthcare Advisory Board for Safaricom, the leading Kenyan telecommunications and mobile money operator.
Dr. Olale began his career at Skirball Institute of Bio-molecular Medicine in New York, where he cloned two genes involved in organ patterning and regeneration. He also worked as a venture capital analyst at New York University’s Office of Industrial Liaison and Applied Research Fund and as an associate partner and a leader in the pharmaceutical, medical products, and global health practices at McKinsey & Company in New York.
Dr. Olale received his medical and doctorate degrees from New York University School of Medicine and a BA in molecular biology from the University of Pennsylvania.